Obesitat
International Journal of Obesity
Clinical Research
Prefronto-cerebellar neuromodulation affects appetite in obesity.
Elena M. Marron · Raquel Viejo-Sobera · Guillem Cuatrecasas · Diego Redolar-Ripoll · Pilar García Lorda · Abhishek Datta · Marom Bikson · Greta Magerowski · Miguel Alonso-Alonso
Hipòfisi i hormona del creixement
Endocrine Connections
Research
GH deficiency in patients with spinal cord injury: efficacy/safety of GH replacement, a pilot study
Guillem Cuatrecasas1,2, Hatice Kumru3,4,5, M Josep Coves1 and Joan Vidal3,4,5
1 Endocrinology Department, Hospital Quiron-Teknon, CPEN S.L., Barcelona, Spain
2 Universitat Oberta Catalunya (UOC), Barcelona, Spain
3 Institut Guttmann, Institut Universitari de Neurorehabilitació Adscrit a la UAB, Barcelona, Spain
4 Univ Autònoma de Barcelona, Cerdanyola del Vallès, Spain
5 Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain
The Official Journal of the Pituitary Society
Pituitary
GH/IGF1 axis disturbances in the fibromyalgia syndrome: is there a rationale for GH treatment?
G. Cuatrecasas, C. Alegre & F. F. Casanueva
PAINÒ153 (2012) 1382–1389
Growth hormone treatment for sustained pain reduction and improvementin quality of life in severe fibromyalgia
Guillem Cuatrecasas, C. Alegreb, J. Fernandez-Solàc, M.J. Gonzalez, F. Garcia-Fructuoso, V. Poca-Dias, A. Nadal, Gabriel Cuatrecasas, F. Navarro, A. Mera, M. Lage, R. Peinó, F. Casanueva, C. Liñan, G. Sesmilo, M.J. Coves, J.P. Izquierdo, I. Alvarez, E. Granados, M. Puig-Domingo.
Endocrine Care
High Prevalence of Growth Hormone Deficiency inSevere Fibromyalgia Syndromes
G. Cuatrecasas, M. J. Gonzalez, C. Alegre, G. Sesmilo, J. Fernandez-Solà, F. F. Casanueva, F. Garcia-Fructuoso, V. Poca-Dias, J. P. Izquierdo, and M. Puig-Domingo
Endocrinology Department (G.C.), Centro Médico Teknon and Clinica Sagrada Familia, 08022 Barcelona, Spain; Rheumatology Department (M.J.G., C.A.) and Endocrinology Department (G.S.), Institut Universitari Dexeus, 08028 Barcelona, Spain; Internal Medicine Department (J.F.-S.), Hospital Clinic Universitat Barcelona, 08036 Barcelona, Spain; Universidad Santiago Compostela (F.F.C.), 15705 Santiago, Spain; Rheumatology Department (F.G.-F., V.P.-D.), International Centre of Advanced Medicine Clinic, 08017 Barcelona, Spain; Merck Farma y Química (J.P.I.), 08100 Barcelona, Spain; and Endocrinology Department (M.P.-D.), Hospital Clinic Universitat Barcelona, 08036 Barcelona, Spain
Suprarrenal
Research Article
Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers
Gloria Aranda,1,2 Cristina Lopez,3 Rebeca Fernandez-Ruiz,4 Yaiza Esteban,4 Guillermo Garcia-Eguren,1 Mireia Mora,1,2,4,5 Irene Halperin,1,2,4,5 Gregori Casals,6 Joaquim Enseñat,5,7 and Felicia A. Hanzu1,2,4,5
1 Group of Endocrine Disorders, IDIBAPS, Barcelona, Spain 2 Department of Endocrinology and Nutrition, Hospital Clinic Universitari, Barcelona, Spain 3 Cytometry Department, IDIBAPS, Barcelona, Spain 4 Centro de Investigación en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain 5 University of Barcelona, Barcelona, Spain 6 Biochemistry and Molecular Genetics Service, Hospital Clinic Universitari and IDIBAPS and CIBERehd, Barcelona, Spain 7 Department of Neurosurgery, Hospital Clinic Universitari, Barcelona, Spain
The Official Journal of the Pituitary Society
Pituitary
Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing’s syndrome
G. Aranda, M. Careaga, F. A. Hanzu, I. Patrascioiu, P. Ríos, M. Mora, B. Morales-Romero, W. Jiménez, I. Halperin & G. Casals
